Status
Conditions
Treatments
About
Sleepiness is frequent in parkinsonian patients, increasing with the duration of disease. By patients with motor fluctuations, continuous dopaminergic delivery devices or deep brain stimulation are justified to improve the motor prognosis. Antiparkinsonian treatments, especially dopaminergic agonists, may worsen the sleepiness and thus affect the quality of life. The investigators aimed to monitor sleepiness in parkinsonian patients before and during treatment with continous dopaminergic delivery device or deep brain stimulation.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
30 participants in 3 patient groups
Loading...
Central trial contact
Nicolas Carpentier
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal